Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
Phase of Trial: Phase I/II
Latest Information Update: 18 Mar 2014
At a glance
- Drugs Mifepristone (Primary)
- Indications Generalised anxiety disorder; Panic disorder
- Focus Adverse reactions; Therapeutic Use
- 18 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Mar 2013 Planned end date changed from 1 Dec 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 27 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.